Pancreatic Cancer Research

Clinical trialObsUnknown

International Pancreatic Surgery Outcomes Study - PancreasGroup.Org

PancreasGroup.Org - International Pancreatic Surgery Outcomes Study

Outcome
Outcome unknown
Phase
Obs
Status
Unknown
Study type
Observational
Start
September 2021
Expected end
31 March 2022
Enrollment
3,500 participants
Sites
0
Primary outcomes
Mortality
Sponsor
Other
Results posted
No
Last update
16 September 2021

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

"Snapshot" study worldwide over 3 months in 2021. Provide a verified record of true morbidity and mortality. Identify modifiable predicting factors of outcome. Obtain PubMed citable co-authorship,

Detailed description public domain (ClinicalTrials.gov)

The PancreasGroup.org team is conducting a "snapshot" clinical study investigating the outcomes of pancreatic surgery worldwide. This "collaborative" model for snapshot clinical studies is a well-established approach for assessing current practice in a short period of time. There will be 3 months of prospective enrolment and 3 months follow up within a 12-month frame. The study will provide highly valuable data on outcomes after pancreatic surgery. The investigators are aiming at providing a verified record of true morbidity and mortality in consecutive unselected patients. This way the investigators will help identify relevant, modifiable predicting factors for outcome after pancreatic surgery.